BEACLE INC has a total of 19 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Japan, United States and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and micro-structure and nano-technology are TECON BIOLOGICAL CO LTD, ZHEJIANG PUKANG BIOTECHNOLOGY CO LTD and I D BIO.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 5 | |
#2 | United States | 4 | |
#3 | China | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Micro-structure and nano-technology | |
#4 | Foods and drinks | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Nanostructure applications | |
#6 | Enzymes | |
#7 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Oda Yasunori | 9 |
#2 | Goh Yasumasa | 8 |
#3 | Ueda Masakazu | 6 |
#4 | Kondo Akihiko | 6 |
#5 | Ohashi Chinatsu | 6 |
#6 | Tanizawa Katsuyuki | 6 |
#7 | Kuroda Shunichi | 5 |
#8 | Isotani Kentaro | 5 |
#9 | Chuah Marinee | 3 |
#10 | Vandendriessche Thierry | 3 |
Publication | Filing date | Title |
---|---|---|
WO2018225731A1 | Virus-like particles to be used for causing immune response against hbv | |
JP2018059754A | Automatic reacting device | |
WO2016017037A1 | Virus-like particle to be used in immunoassay method, blocking agent to be used therein and kit comprising same | |
JP2010210444A | Nanoparticles for simultaneous detection of multiple antigen | |
JP2010077091A | METHOD FOR ENCAPSULATION OF siRNA AND CELL-SELECTIVE INTRODUCTION OF siRNA BY USING HOLLOW BIO-NANOCAPSULE OF HEPATITIS B VIRUS PROTEIN AND LIPOSOME | |
JP2006265152A | Cancer-treating medicinal agent and method for producing the same | |
JP2004277355A | Medicament for treating hemophilia and method for treating hemophilia by using the same |